128 related articles for article (PubMed ID: 29503576)
1. Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada.
Tarride JE; Hopkins RB; Burke N; Guertin JR; O'Reilly D; Fell CD; Dion G; Kolb M
Clinicoecon Outcomes Res; 2018; 10():127-137. PubMed ID: 29503576
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.
Hopkins RB; Burke N; Fell C; Dion G; Kolb M
Eur Respir J; 2016 Jul; 48(1):187-95. PubMed ID: 27230442
[TBL] [Abstract][Full Text] [Related]
3. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
Collard HR; Chen SY; Yeh WS; Li Q; Lee YC; Wang A; Raghu G
Ann Am Thorac Soc; 2015 Jul; 12(7):981-7. PubMed ID: 25923447
[TBL] [Abstract][Full Text] [Related]
4. Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients.
Farrand E; Iribarren C; Vittinghoff E; Levine-Hall T; Ley B; Minowada G; Collard HR
Chest; 2021 Jan; 159(1):219-227. PubMed ID: 32717266
[TBL] [Abstract][Full Text] [Related]
5. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study.
Cox IA; de Graaff B; Ahmed H; Campbell J; Otahal P; Corte TJ; Moodley Y; Goh N; Hopkins P; Macansh S; Walters EH; Palmer AJ
Eur J Health Econ; 2023 Sep; 24(7):1121-1139. PubMed ID: 36289130
[TBL] [Abstract][Full Text] [Related]
6. Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic.
Kalluri M; Lu-Song J; Younus S; Nabipoor M; Richman-Eisenstat J; Ohinmaa A; Bakal JA
Ann Am Thorac Soc; 2020 Jun; 17(6):706-713. PubMed ID: 32197048
[No Abstract] [Full Text] [Related]
7. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
[TBL] [Abstract][Full Text] [Related]
8. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
Fan Y; Bender SD; Conoscenti CS; Davidson-Ray L; Cowper PA; Palmer SM; de Andrade JA;
Chest; 2020 Jun; 157(6):1522-1530. PubMed ID: 32004554
[TBL] [Abstract][Full Text] [Related]
9. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study.
Gupta R; Morgan AD; George PM; Quint JK
Thorax; 2024 Jun; 79(7):624-631. PubMed ID: 38688708
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study.
Raimundo K; Chang E; Broder MS; Alexander K; Zazzali J; Swigris JJ
BMC Pulm Med; 2016 Jan; 16():2. PubMed ID: 26732054
[TBL] [Abstract][Full Text] [Related]
11. Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England.
Morgan A; Gupta RS; George PM; Quint JK
BMC Pulm Med; 2023 Jul; 23(1):256. PubMed ID: 37434192
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic pulmonary fibrosis in Taiwan - a population-based study.
Lai CC; Wang CY; Lu HM; Chen L; Teng NC; Yan YH; Wang JY; Chang YT; Chao TT; Lin HI; Chen CR; Yu CJ; Wang JD
Respir Med; 2012 Nov; 106(11):1566-74. PubMed ID: 22954482
[TBL] [Abstract][Full Text] [Related]
13. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
14. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.
Fernández Pérez ER; Daniels CE; Schroeder DR; St Sauver J; Hartman TE; Bartholmai BJ; Yi ES; Ryu JH
Chest; 2010 Jan; 137(1):129-37. PubMed ID: 19749005
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.
Nalysnyk L; Cid-Ruzafa J; Rotella P; Esser D
Eur Respir Rev; 2012 Dec; 21(126):355-61. PubMed ID: 23204124
[TBL] [Abstract][Full Text] [Related]
16. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
Mortimer K; Hartmann N; Chan C; Norman H; Wallace L; Enger C
BMC Pulm Med; 2019 Jan; 19(1):11. PubMed ID: 30630460
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.
Harari S; Madotto F; Caminati A; Conti S; Cesana G
PLoS One; 2016; 11(2):e0147072. PubMed ID: 26841042
[TBL] [Abstract][Full Text] [Related]
18. Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement.
Gjonbrataj J; Choi WI; Bahn YE; Rho BH; Lee JJ; Lee CW
Int J Tuberc Lung Dis; 2015 Jun; 19(6):742-6. PubMed ID: 25946370
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary Fibrosis.
Yang SN; Perng DW; Ko HK; Chang YL; Hsu CC; Huang HY; Chung MI
Healthcare (Basel); 2020 Dec; 8(4):. PubMed ID: 33371337
[TBL] [Abstract][Full Text] [Related]
20. Health care burden and medical resource utilisation of idiopathic pulmonary fibrosis in Korea.
Kim SW; Myong JP; Yoon HK; Koo JW; Kwon SS; Kim YH
Int J Tuberc Lung Dis; 2017 Feb; 21(2):230-235. PubMed ID: 28234090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
